AKT1 and Cognitive impairment: Furthermore, guidance from Health Canada and the National Institute on Health Abuse strongly suggest that polymorphisms of AKT1 and COMT genes can impact response to cannabis use and predict the potential risk of developing psychosis and cognitive impairment, respectively (Morgan et al. 2016; Radhakrishnan et al. 2014; Health Canada n.d.).